SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat ($SOLYCAT) is trending amid community excitement surrounding its recent listing on Phantom Wallet. Positive sentiment suggests potential gains, with many referring to it as a hidden gem within the Solana ecosystem. The listing appears to be a catalyst for increased attention and discussion.

The $ROSIE project centers around a unique, AI-powered memecoin inspired by "Rosie the Robot," a beloved character known for her role as a caring, motherly robot in popular culture. The purpose of $ROSIE is twofold: entertainment through an interactive AI feature and social impact via charitable donations.  Users can interact with an AI version of Rosie on the project’s website, where they can ask questions and engage in conversations. The utility of $ROSIE goes beyond typical memecoins by enabling users to donate tokens, which will be directed towards charitable causes supporting mothers. Through this initiative, the project combines the viral appeal of meme tokens with meaningful contributions to social causes, while leveraging AI technology to create a novel user experience.

Rosie the Robot

ROSIE CRYPTO is gaining attention, particularly regarding its integration with Phantom Wallet. The community highlights the token's 'early moon' potential and strong momentum, suggesting a possible breakout. Bullish sentiment is building, with many emphasizing it as an opportune entry point.

TOSHI

TOSHI is trending as community members discuss its potential for a significant rally, pointing to its strong performance relative to other cryptocurrencies during a recent market dip. Bullish sentiment is fueled by anticipation of exchange listings and the coin's position as the 'face of Base,' with some community members speculating on a possible breakout to new all-time highs. Community buzz highlights the coin's strong support level and growing holder base.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals ($SNDX) is trending due to an upcoming FDA decision on their drug Revuforj for a specific type of leukemia, with the community debating the likelihood of approval and its potential impact. Some traders point to the drug's existing approval for a related condition and analysts' price targets while others cite concerns about side effects and market manipulation. Discussions also mention potential competition and buyout scenarios.

An AI x Metaverse Protocol that is building the future of virtual interactions.

Virtual Protocol

Virtual Protocol is trending due to recent listing news and a surge in interest surrounding its AI agent ecosystem. Community members are actively discussing its potential, the utility of its agents, and possible price targets. The broader context includes the growing excitement around AI-related crypto projects and Base network tokens.

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits.

$PAW is trending amidst community excitement surrounding its multi-chain ecosystem and ongoing development, including news about new projects launching and validator updates. Community members express bullish sentiment, focusing on the project's potential for growth and interoperability. Discussions also highlight staking and upcoming partnerships.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin ($BNKR) is trending due to recent price pumps, leading to community excitement about potentially "dropping a zero."  Many allude to the project's fundamentals, AI integration, and association with the Base network as reasons for optimism.  Traders are closely watching resistance levels, volume, and overall market conditions for potential breakouts.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a significant surge potentially fueled by news of insider buying, a milestone payment from Merck related to their Alzheimer's program, and strong Q3 earnings. The community is actively discussing the low float and potential for a short squeeze, with some speculating about a potential run to double digits. However, some traders caution about potential dilution and the recent failed drug trial.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as the community debates the stock's future following its recent FDA approval, with some expressing frustration over the share price decline and raising concerns about potential dilution. Others remain optimistic, pointing to the drug's potential, BlackRock's increased stake, and a possible short squeeze. Discussions also involve the company's management and upcoming catalysts.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

$SLAP is gaining attention as community members rally around its unique branding and real-world partnerships, including sponsored athletes like Karolina Arm, a pro MMA fighter. The community is excited about Arm's upcoming fight and appreciates the team's consistent efforts. Many highlight that $SLAP is more than just a meme; it represents a lifestyle and a dedicated community.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SDIG, KAVL, WMPN, ALVR on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SDIG, KAVL, WMPN, ALVR on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SDIG, KAVL, WMPN, ALVR on Behalf of...

SHAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of EMKR, CCRN, WMPN, ALVR to Act Now

SHAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of EMKR, CCRN, WMPN, ALVR to Act Now SHAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of EMKR, CCRN, WMPN...

ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc. - ALVR

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of AlloVir, Inc. (the Company) (NasdaqCM: ALVR...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMPN, ALVR, BERY on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMPN, ALVR, BERY on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMPN, ALVR, BERY on Behalf of Shareholders...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AZPN, LRFC, ALVR on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AZPN, LRFC, ALVR on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AZPN, LRFC, ALVR on Behalf of...

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates WMPN, ALVR, CYTH on Behalf of Shareholders

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates WMPN, ALVR, CYTH on Behalf of Shareholders SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates WMPN, ALVR, CYTH on Behalf of Shareholders PR Newswire...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, CYTH, ALVR on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, CYTH, ALVR on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, CYTH, ALVR on Behalf of Shareholders...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, STAF, ALVR on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, STAF, ALVR on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, STAF, ALVR on Behalf of Shareholders...

STOCKHOLDER ALERT: The MandA Class Action Firm Continues To Investigate Merger - AVTE, BCOV, ALVR, AE

STOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger - AVTE, BCOV, ALVR, AE STOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger - AVTE, BCOV, ALVR, AE...

$HAREHOLDER INVESTIGATION: The MandA Class Action Firm Continues to Investigate the Mergers of ENLC, ALVR, and CYTH

$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of ENLC, ALVR, and CYTH $HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the...

Kalaris Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for retinal diseases. It is focusing on developing TH103, a novel anti-VEGF agent targeted at treating neovascular and exudative retinal diseases. The company is headquartered in Palo Alto, CA.

AlloVir Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

ALVR
AlloVir Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ALVR News

ALVRAlloVir Inc